|1.||Rafatpanah, Houshang: 1 article (03/2015)|
|2.||Ghayour Mobarhan, Majid: 1 article (03/2015)|
|3.||Rezaee, Seyed Abdolrahim: 1 article (03/2015)|
|4.||Hassannia, Tahereh: 1 article (03/2015)|
|5.||Valizadeh, Narges: 1 article (03/2015)|
|6.||Hekmat, Reza: 1 article (03/2015)|
|7.||Ahmadi Ghezeldasht, Sanaz: 1 article (03/2015)|
|8.||Winkler, Laura: 1 article (12/2011)|
|9.||Kalejta, Robert F: 1 article (12/2011)|
|10.||Hwang, Jiwon: 1 article (12/2011)|
|1.||Surface Antigens (Surface Antigen)IBA
|5.||Complement System Proteins (Complement)IBA
10/21/1992 - "This antigen was not detected in normal epidermal and Shope papilloma cells of rabbits but was present in the outer sheath cells of hair follicles of normal rabbit skin. "
07/01/1968 - "Verrucae: virus structure, localization of antigens, and comparison with the Shope papilloma."
11/01/1967 - "The Vx2 and Vx7 rabbit carcinomas, both of Shope papilloma derivation, were cultivated in vitro and studied for immunofluorescence indicative of the presence of viral antigen. "
09/01/1967 - "[Symposium on the "cancer virus" 5. Virus antigen in Shope papilloma and carcinogenic cells]."
06/30/1994 - "Immunohistochemical analysis of the primary carcinoma tissue revealed that the antibody intensely stained keratinizing carcinoma cells with marked shrinkage whereas it did not stain normal epidermal keratinizing rabbit cells or benign tumor (Shope papilloma) cells, suggesting that the antigen expression in vivo was closely correlated with terminal differentiation of the carcinoma cells. "
06/01/1978 - "I. Comparison of structural polypeptides in vaccina, cowpox and Shope fibroma viruses."
08/01/1979 - "Serologically cross-reactive polypeptides in vaccinia, cowpox and Shope fibroma viruses."
09/01/1978 - "II. Comparison of virus-induced polypeptides in cells infected with vaccinia, cowpox and Shope fibroma viruses."
06/01/1978 - "The profile of polypeptide bands of cowpox virions was also almost the same as that of vaccinia virions, except for several polypeptides of about 40,000 to 50,000 daltons, but the profile of Shope fibroma virions differed considerably from that of vaccinia or cowpox virions."
09/01/1978 - "Comparative studies of virus-induced polypeptides on the basis of migration in SDS-polyacrylamide gel electrophoresis revealed that 11 polypeptides were early polypeptides common to both vaccinia and cowpox viruses; 21 were late polypeptides common to both vaccinia and cowpox viruses; 4 were early polypeptides common to both vaccinia and Shope fibroma viruses; 7 were late polypeptides common to both vaccinia and Shope fibroma viruses; 5 were early polypeptides common to both cowpox and Shope fibroma viruses; 9 were late polypeptides common to both cowpox and Shope fibroma viruses; 4 were early polypeptides common to all three viruses; and 7 were late polypeptides common to all three viruses."
|9.||Tretinoin (Retinoic Acid)FDA LinkGeneric
|10.||Proteins (Proteins, Gene)IBA
10/01/1993 - "p65 is a new member of the family of poxvirus proteins including vaccinia virus proteins A55R, C2L and F3L, and a group of related proteins of leporipoxviruses, Shope fibroma and myxoma viruses (T6, T8, T9, M9). "
02/01/1995 - "Tumor necrosis factor (TNF-alpha) interacts with two transmembrane receptor proteins, p55TNFR and p75TNFR, which are members of a family of cell surface molecules that include the Fas antigen, CD27, CD30, CD40, OX40, a Shope fibroma viral protein, and the low-affinity p75 neurotrophin receptor. "
|1.||Renal Dialysis (Hemodialysis)
03/01/2015 - "In conclusion, this study demonstrated that these tumor virus infections including HTLV-I, KSHV and particularly hepatitis viruses (HBV plus HCV) are prevalent in the general population and in patients on hemodialysis, which might be an important health concern in this region due to the mobile population."
|3.||Transplantation (Transplant Recipients)
12/01/2011 - "In this review, we identify and describe examples of proteasome-dependent, ubiquitin-independent protein degradation that occur during tumor virus infections, speculate why this type of protein destruction may be preferred during oncogenesis, and argue that this uncommon type of protein turnover represents a prime target for antiviral and anticancer therapeutics."